Biopharmaceutics: Drug Metabolism and Pharmacokinetics: The Effect of Protein Binding on the Hepatic First Pass of O‐Acyl Salicylate Derivatives in the Rat

In this work the in‐situ perfused rat liver has been used to examine the effect of changing the protein content of the perfusate on the hepatic extraction of O ‐acyl esters of salicylic acid. The hepatic availability (F) of these solutes was studied at a flow‐rate of 30 mL min −1 with perfusate albumin concentrations of 0, 2, and 4% w/v. The hepatic availability of the esters was shown to decrease with increasing carbon‐chain length in the O ‐acyl group; for all the esters the hepatic availability increased with increasing albumin concentration in the perfusate. The dispersion‐model‐derived efficiency number (R N ) of the esters was shown to increase with increasing lipophilicity and decrease with increasing albumin concentration in the perfusate. The unbound fraction (f u ) of the esters decreased with lipophilicity. R N /f u for acetylsalicylic acid remained relatively constant as the albumin concentration was increased. However, R N /f u for n ‐pentanoyl‐and n ‐hexanoylsalicylic acids increased significantly as albumin concentration increased from 0% to 4%. Thus, for the more lipophilic solutes ( n ‐pentanoyl‐ and n ‐hexanoylsalicylic acids) the presence of albumin apparently facilitates the uptake of unbound solute relative to acetylsalicylic acid.